Cargando…

Study on Qi Deficiency Syndrome Identification Modes of Coronary Heart Disease Based on Metabolomic Biomarkers

Coronary heart disease (CHD) is one of the most important types of heart disease because of its high incidence and mortality. With the era of systems biology bursting into reality, the analysis of the whole biological systems whether they are cells, tissues, organs, or the whole organisms has now be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Qi, Zhao, Huihui, Chen, Jianxin, Li, Youlin, Li, Zhongfeng, Wang, Juan, Wang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985201/ https://www.ncbi.nlm.nih.gov/pubmed/24795766 http://dx.doi.org/10.1155/2014/281829

Ejemplares similares

Identification of metabolic biomarkers in patients with type 2 diabetic coronary heart diseases based on metabolomic approach
por: Liu, Xinfeng, et al.
Publicado: (2016)

Discovery of Diagnosis Pattern of Coronary Heart Disease with Qi Deficiency Syndrome by the T-Test-Based Adaboost Algorithm
por: Zhao, Huihui, et al.
Publicado: (2011)

Study on TCM Syndrome Identification Modes of Coronary Heart Disease Based on Data Mining
por: Shi, Qi, et al.
Publicado: (2012)

Circulating MicroRNA Profiles Differ between Qi-Stagnation and Qi-Deficiency in Coronary Heart Disease Patients with Blood Stasis Syndrome
por: Hou, Jincai, et al.
Publicado: (2014)

Metabolomics-Based Study of Clinical and Animal Plasma Samples in Coronary Heart Disease with Blood Stasis Syndrome
por: Zhao, Huihui, et al.
Publicado: (2012)

Phenomics Research on Coronary Heart Disease Based on Human Phenotype Ontology
por: Shi, Qi, et al.
Publicado: (2014)

Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome
por: Tao, Fangfang, et al.
Publicado: (2017)

Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
por: Zhang, Jun, et al.
Publicado: (2022)

Identification of potential plasma biomarkers and metabolic dysfunction for unstable angina pectoris and its complication based on global metabolomics
por: Wang, Juan, et al.
Publicado: (2019)

Application of Metabolomics to Identify Potential Biomarkers for the Early Diagnosis of Coronary Heart Disease
por: Jiang, Huali, et al.
Publicado: (2021)

Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease
por: Chang, Hong, et al.
Publicado: (2016)

Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
por: Zhang, Jun, et al.
Publicado: (2022)

Integrated Analyses of lncRNA and mRNA Profiles Reveal Characteristic and Functional Changes of Leukocytes in Qi-Deficiency Constitution and Pi-Qi-Deficiency Syndrome of Chronic Superficial Gastritis
por: You, Leiming, et al.
Publicado: (2020)

Xiaopiyishen Herbal Extract Granule Improves the Quality of Life among People with Fatigue-Predominant Subhealth and Liver-Qi Stagnation and Spleen-Qi Deficiency Syndrome
por: Xue, Xiao-lin, et al.
Publicado: (2012)

Urinary metabolomics reveals the therapeutic effect of HuangQi Injections in cisplatin-induced nephrotoxic rats
por: Li, Chang-Yin, et al.
Publicado: (2017)

A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-Compound, Multi-Target, Multi-Pathway Mode of Action
por: Li, Xiang, et al.
Publicado: (2014)

Cardioprotective Effects of QiShenYiQi Dripping Pills on Transverse Aortic Constriction-Induced Heart Failure in Mice
por: Ruan, Guoran, et al.
Publicado: (2018)

Serum metabolomics analysis of biomarkers and metabolic pathways in patients with colorectal cancer associated with spleen-deficiency and qi-stagnation syndrome or damp-heat syndrome: a prospective cohort study
por: Zou, Min, et al.
Publicado: (2023)

A Randomized Controlled Study of the Yi Qi Gu Biao Pill in the Treatment of Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome)
por: Zhen, Gao, et al.
Publicado: (2017)

Effect and Mechanism of QiShenYiQi Pill on Experimental Autoimmune Myocarditis Rats
por: Lv, Shichao, et al.
Publicado: (2016)

Network Pharmacology to Uncover the Biological Basis of Spleen Qi Deficiency Syndrome and Herbal Treatment
por: Wang, Xin, et al.
Publicado: (2020)

Dr QI - A quality improvement (QI) approach to designing and delivering QI training
por: Krishnan, Deepa Bagepalli, et al.
Publicado: (2021)

Toxicological Risks of Renqingchangjue in Rats Evaluated by (1)H NMR-Based Serum and Urine Metabolomics Analysis
por: Wang, Xia, et al.
Publicado: (2020)

QiShenYiQi Pill Improves Myocardial Hypertrophy Caused by Pressure Overload in Rats
por: Lv, Shichao, et al.
Publicado: (2021)

QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode
por: Chen, Yuan-Yuan, et al.
Publicado: (2015)

Clinical Data Mining of Phenotypic Network in Angina Pectoris of Coronary Heart Disease
por: Chen, Jianxin, et al.
Publicado: (2012)

Investigation of Invigorating Qi and Activating Blood Circulation Prescriptions in Treating Qi Deficiency and Blood Stasis Syndrome of Ischemic Stroke Patients: Study Protocol for a Randomized Controlled Trial
por: Wang, Yu, et al.
Publicado: (2020)

What Is Qi?
por: Flowers, James
Publicado: (2006)

Qi-Deficiency Related Increases in Disease Susceptibility Are Potentially Mediated by the Intestinal Microbiota
por: Ma, Ke, et al.
Publicado: (2018)

QiShenYiQi Inhibits Tissue Plasminogen Activator–Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice
por: Ye, Yang, et al.
Publicado: (2022)

Effect of QiShenYiQi Pill on Myocardial Collagen Metabolism in Rats with Partial Abdominal Aortic Coarctation
por: Lv, Shichao, et al.
Publicado: (2015)

Validation of the qi blood yin yang deficiency questionnaire on chronic fatigue
por: Kim, Jihye, et al.
Publicado: (2016)

Identification of DNA methylation-regulated genes as potential biomarkers for coronary heart disease via machine learning in the Framingham Heart Study
por: Zhang, Xiaokang, et al.
Publicado: (2022)

QiShenYiQi pill improves the reparative myocardial fibrosis by regulating autophagy
por: Lv, Shichao, et al.
Publicado: (2020)

Exploring metabolomics biomarkers for evaluating the effectiveness of concurrent radiochemotherapy for cervical cancers
por: Zhou, Huihui, et al.
Publicado: (2020)

Identification of Metabolomic Biomarkers of Seed Vigor and Aging in Hybrid Rice
por: Chen, Bing-Xian, et al.
Publicado: (2022)

Pharmacological Network Reveals the Active Mechanism of Qi-Replenishing, Spleen-Strengthening, Phlegm-Dispelling, and Blood-Nourishing Fufang on Coronary Heart Disease
por: Zhang, Fan, et al.
Publicado: (2020)

Tissue metabolomics study to reveal the toxicity of a traditional Tibetan medicine ‘Renqing Changjue’ in rats
por: Xu, Can, et al.
Publicado: (2018)

Commentary: A Comment on Qi et al.—Authors’ Reply
por: Qi, X. Sharon, et al.
Publicado: (2012)

QiShenYiQi Attenuates Renal Interstitial Fibrosis by Blocking the Activation of β-Catenin
por: Zhou, Zhanmei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k4ablco62sr2u5m4su6bn2dh9b